Pfizer is to invest $200m to improve the company’s biotechnology manufacturing plant in Clondalkin, County Dublin, Ireland.

The company’s Grange Castle facility will receive two new processing suites in order to expand its production and testing capacity, enhancing on the capabilities of what is already one of the world’s largest biotech facilities.

Pfizer CFO Frank D’Amelio noted that Ireland is a prime location for major investment, citing the fact that pharmaceutical and chemical products account for over 50% of Irish exports.

Pfizer currently produces two blockbuster products at the Grange Castle plant – pneumococcal disease vaccine Prevnar and arthritis medication Enbrel.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.